DK2076502T3 - Substituerede carboxamider som antagonister af gruppe-1 metabotrope receptorer - Google Patents
Substituerede carboxamider som antagonister af gruppe-1 metabotrope receptorerInfo
- Publication number
- DK2076502T3 DK2076502T3 DK07873705.3T DK07873705T DK2076502T3 DK 2076502 T3 DK2076502 T3 DK 2076502T3 DK 07873705 T DK07873705 T DK 07873705T DK 2076502 T3 DK2076502 T3 DK 2076502T3
- Authority
- DK
- Denmark
- Prior art keywords
- antagonists
- group
- metabotropic receptors
- substituted carboxamides
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81183906P | 2006-06-08 | 2006-06-08 | |
| PCT/US2007/070572 WO2008103185A2 (en) | 2006-06-08 | 2007-06-07 | Substituted carboxamides as group i metabotropic receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2076502T3 true DK2076502T3 (da) | 2011-07-25 |
Family
ID=39673278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07873705.3T DK2076502T3 (da) | 2006-06-08 | 2007-06-07 | Substituerede carboxamider som antagonister af gruppe-1 metabotrope receptorer |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US7960419B2 (da) |
| EP (1) | EP2076502B1 (da) |
| JP (1) | JP5108878B2 (da) |
| KR (1) | KR101051559B1 (da) |
| CN (1) | CN101466691B (da) |
| AT (1) | ATE509921T1 (da) |
| AU (1) | AU2007347428B2 (da) |
| BR (1) | BRPI0712862A2 (da) |
| CA (1) | CA2652074C (da) |
| CR (1) | CR10410A (da) |
| CY (1) | CY1111588T1 (da) |
| DK (1) | DK2076502T3 (da) |
| EA (1) | EA014233B1 (da) |
| EC (1) | ECSP088939A (da) |
| ES (1) | ES2362949T3 (da) |
| HK (1) | HK1131984A1 (da) |
| HR (1) | HRP20110436T1 (da) |
| IL (1) | IL195632A (da) |
| MA (1) | MA30620B1 (da) |
| MX (1) | MX2008015485A (da) |
| MY (1) | MY148084A (da) |
| NO (1) | NO341474B1 (da) |
| NZ (1) | NZ573352A (da) |
| PL (1) | PL2076502T3 (da) |
| PT (1) | PT2076502E (da) |
| RS (1) | RS51818B (da) |
| SI (1) | SI2076502T1 (da) |
| TN (1) | TNSN08506A1 (da) |
| UA (1) | UA95480C2 (da) |
| WO (1) | WO2008103185A2 (da) |
| ZA (1) | ZA200809111B (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0804685D0 (en) | 2008-03-13 | 2008-04-16 | Univ Edinburgh | Therapeutic compounds and their use |
| JO2775B1 (en) | 2008-04-04 | 2014-03-15 | ايلي ليلي اند كومباني | 3-indazolil 4-pyridyl isothiazole |
| US20120095046A1 (en) * | 2009-06-15 | 2012-04-19 | The University Of Edinburgh | Amido-Isothiazole Compounds and Their Use as Inhibitors of 11Beta-HSD1 for the Treatment of Metabolic Syndrome and Related Disorders |
| JP5779181B2 (ja) | 2009-09-16 | 2015-09-16 | ザ ユニバーシティ オブ エディンバラ | （４−フェニル−ピペリジン−１−イル）−［５−（１ｈ−ピラゾール−４−イル）−チオフェン−３−イル］−メタノン化合物及びそれらの使用 |
| JP5899202B2 (ja) | 2010-04-29 | 2016-04-06 | ザ ユニバーシティ オブ エディンバラ | １１β−ＨＳＤ１の阻害剤としての３，３−二置換−（８−アザ−ビシクロ［３．２．１］オクタ−８−イル）−［５−（１Ｈ−ピラゾール−４−イル）−チオフェン−３−イル］−メタノン類 |
| KR102160841B1 (ko) | 2012-11-13 | 2020-09-28 | 닛산 가가쿠 가부시키가이샤 | 2-피리돈 화합물 |
| KR20190053242A (ko) | 2016-09-23 | 2019-05-17 | 바이엘 악티엔게젤샤프트 | N3-시클릭 치환된 티에노우라실 및 그의 용도 |
| CN117567266B (zh) * | 2023-11-07 | 2024-06-14 | 康龙化成手性医药技术(宁波)有限公司 | 一种制备2-甲基环丙羧酸的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL72091A0 (en) * | 1983-06-20 | 1984-10-31 | Lilly Co Eli | N'-substituted(3-aryl 5-isothiazolyl)urea derivatives |
| DE4328425A1 (de) * | 1993-08-24 | 1995-03-02 | Basf Ag | Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung |
| DK124393D0 (da) * | 1993-11-03 | 1993-11-03 | Lundbeck & Co As H | Compounds |
| DE19542372A1 (de) * | 1995-11-14 | 1997-05-15 | Bayer Ag | Acylierte 5-Aminoisothiazole |
| UA60365C2 (uk) * | 1998-06-04 | 2003-10-15 | Пфайзер Продактс Інк. | Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця |
| JP3411262B2 (ja) * | 1999-08-20 | 2003-05-26 | 萬有製薬株式会社 | 新規スピロ化合物 |
| IL159926A0 (en) * | 2001-08-06 | 2004-06-20 | Pharmacia Italia Spa | Aminoisoxazole derivatives active as kinase inhibitors |
| WO2005030128A2 (en) * | 2003-09-23 | 2005-04-07 | Merck & Co., Inc. | Pyrazole modulators of metabotropic glutamate receptors |
| US7326729B2 (en) * | 2004-05-12 | 2008-02-05 | Schering Corporation | CXCR1 and CXCR2 chemokine antagonists |
| EP1794156A2 (en) * | 2004-09-23 | 2007-06-13 | Pfizer Products Incorporated | Trombopoietin receptor agonists |
-
2007
- 2007-06-07 PL PL07873705T patent/PL2076502T3/pl unknown
- 2007-06-07 CA CA2652074A patent/CA2652074C/en not_active Expired - Fee Related
- 2007-06-07 SI SI200730695T patent/SI2076502T1/sl unknown
- 2007-06-07 NZ NZ573352A patent/NZ573352A/en not_active IP Right Cessation
- 2007-06-07 JP JP2009514523A patent/JP5108878B2/ja not_active Expired - Fee Related
- 2007-06-07 AT AT07873705T patent/ATE509921T1/de active
- 2007-06-07 KR KR1020087029772A patent/KR101051559B1/ko not_active IP Right Cessation
- 2007-06-07 MX MX2008015485A patent/MX2008015485A/es active IP Right Grant
- 2007-06-07 WO PCT/US2007/070572 patent/WO2008103185A2/en active Application Filing
- 2007-06-07 PT PT07873705T patent/PT2076502E/pt unknown
- 2007-06-07 US US12/300,415 patent/US7960419B2/en active Active
- 2007-06-07 ES ES07873705T patent/ES2362949T3/es active Active
- 2007-06-07 CN CN2007800211890A patent/CN101466691B/zh not_active Expired - Fee Related
- 2007-06-07 BR BRPI0712862-2A patent/BRPI0712862A2/pt not_active IP Right Cessation
- 2007-06-07 AU AU2007347428A patent/AU2007347428B2/en not_active Ceased
- 2007-06-07 MY MYPI20084973A patent/MY148084A/en unknown
- 2007-06-07 EP EP07873705A patent/EP2076502B1/en active Active
- 2007-06-07 RS RS20110336A patent/RS51818B/en unknown
- 2007-06-07 EA EA200870516A patent/EA014233B1/ru not_active IP Right Cessation
- 2007-06-07 UA UAA200813907A patent/UA95480C2/uk unknown
- 2007-06-07 DK DK07873705.3T patent/DK2076502T3/da active
- 2007-10-29 CR CR10410A patent/CR10410A/es unknown
-
2008
- 2008-10-23 ZA ZA200809111A patent/ZA200809111B/xx unknown
- 2008-12-01 IL IL195632A patent/IL195632A/en not_active IP Right Cessation
- 2008-12-02 NO NO20085028A patent/NO341474B1/no not_active IP Right Cessation
- 2008-12-03 EC EC2008008939A patent/ECSP088939A/es unknown
- 2008-12-05 TN TNP2008000506A patent/TNSN08506A1/en unknown
-
2009
- 2009-01-06 MA MA31553A patent/MA30620B1/fr unknown
- 2009-12-02 HK HK09111272.7A patent/HK1131984A1/xx not_active IP Right Cessation
-
2011
- 2011-06-09 HR HR20110436T patent/HRP20110436T1/hr unknown
- 2011-06-24 CY CY20111100600T patent/CY1111588T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2076502T3 (da) | Substituerede carboxamider som antagonister af gruppe-1 metabotrope receptorer | |
| CY2024007I1 (el) | Γλυκοπυρανοζυλο-υποκατεστημενα παραγωγα βενζονιτριλιου, φαρμακευτικες συνθεσεις που περιεχουν τετοιες ενωσεις, η χρηση τους και μεθοδοι παρασκευης τους | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| EA201001724A1 (ru) | Производные изоксазола и их применение в качестве потенциирующих средств для метаботропных глутаматных рецепторов | |
| EA200970585A1 (ru) | Бензамидные производные как агонисты ер-рецепторов | |
| DK1856090T3 (da) | Substituerede thiophen-derivater som glucagon-receptorantagonister, fremstilling og terapeutiske anvendelser | |
| UY30141A1 (es) | Nuevas isoindolonas potenciadoras de receptores metabotropicos de glutamato | |
| ECSP088904A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
| EA200870472A1 (ru) | Ингибиторы 11-бета-гидроксистероид-дегидрогеназы типа 1 | |
| MX2010002584A (es) | Derivados de piperidina como agonistas de receptores muscarinicos. | |
| ATE499367T1 (de) | 1,3-dihydroimidazol-2-thionderivate als inhibitoren von dopamin-beta-hydroxylase | |
| CL2007000918A1 (es) | Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica. | |
| ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
| NO20090779L (no) | 5,6-bisaryl-2-pyridin-karboksamidderivater, fremstilling og anvendelse derav i terapeutika som uretosin II receptorantagonister | |
| ATE440833T1 (de) | Antithrombotische diamide | |
| BRPI0716643A2 (pt) | amidas terapêuticas e compostos relacionados | |
| ATE496918T1 (de) | Als a2b-adenosinrezeptorantagonisten geeignete 5- phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazoä4, - büpyridin-2-onderivate | |
| CY1109694T1 (el) | Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης | |
| EA200802104A1 (ru) | Применение композиций, содержащих антагонисты каппа-опиоидных рецепторов, для лечения диссоциативных расстройств | |
| ATE548365T1 (de) | 5-ht7-rezeptorantagonisten | |
| ATE466842T1 (de) | 3-substituierte pyridinderivate als h3- antagonisten | |
| ATE546448T1 (de) | Urotensin-ii-rezeptorantagonisten | |
| WO2007145563A8 (en) | Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor | |
| ATE418553T1 (de) | Histamin-h3-rezeptor inhibitoren, ihre herstellung und therapeutische anwendungen |